Table 1.
Overall n (%) | White non-Latina/Hispanic n (%) | Black non-Latina/Hispanic n (%) | Latina/Hispanic n (%) | p-Value (Black vs. White)a | p-Value (Latina/Hispanic vs. White)b | |
---|---|---|---|---|---|---|
Total unique responsesc | 935 | 380 | 472 | 83 | ||
Check for cancer | 426 (45.6) | 216 (56.8) | 179 (37.9) | 31 (37.3) | <0.01 | <0.01 |
Check for cervical cancer | 254 (27.2) | 133 (35.0) | 107 (22.7) | 14 (16.7) | ||
Check for cancer (general) | 150 (16.0) | 77 (20.3) | 58 (12.3) | 15 (18.1) | ||
Check for vaginal cancer | 17 (1.8) | 3 (0.8) | 13 (2.8) | 1 (1.2) | ||
Check for uterine cancer | 11 (1.2) | 5 (1.3) | 4 (0.8) | 2 (2.4) | ||
Check for ovarian cancer | 3 (0.3) | 0 (0.0) | 3 (0.6) | 0 (0.0) | ||
Check for infections/STDs | 137 (14.7) | 54 (14.2) | 68 (14.4) | 15 (18.1) | 0.74 | 0.32 |
Check for STDs | 93 (9.9) | 36 (9.5) | 49 (10.4) | 8 (9.6) | ||
Check for infections (general) | 34 (3.6) | 12 (3.2) | 17 (3.6) | 5 (6.0) | ||
Check for HPV | 11 (1.2) | 5 (1.3) | 6 (1.3) | 0 (0.0) | ||
Check for yeast infections | 4 (0.4) | 2 (0.5) | 2 (0.4) | 0 (0.0) | ||
Prevent infections/STDs | 3 (0.3) | 1 (0.3) | 0 (0.0) | 2 (2.4) | ||
Check for HIV | 2 (0.2) | 1 (0.3) | 0 (0.0) | 1 (1.2) | ||
Check reproductive system health | 204 (21.8) | 58 (15.3) | 125 (26.4) | 21 (25.3) | <0.01 | 0.02 |
Check reproductive organs (general) | 92 (9.8) | 37 (9.7) | 49 (10.3) | 6 (7.2) | ||
Check the vagina | 69 (7.4) | 9 (2.4) | 51 (10.8) | 9 (10.8) | ||
Check the cervix | 40 (4.3) | 12 (3.2) | 24 (5.1) | 4 (4.8) | ||
Check the uterus | 16 (1.7) | 4 (1.1) | 9 (1.9) | 3 (3.6) | ||
Check general health | 101 (10.8) | 39 (10.3) | 51 (10.8) | 11 (13.3) | 0.64 | 0.38 |
Other response | 4 (0.4) | 0 (0.0) | 4 (0.8) | 0 (0.0) | ||
Check the anus | 1 (0.1) | 0 (0.0) | 1 (0.2) | 0 (0.0) | ||
Check for pregnancy | 1 (0.1) | 0 (0.0) | 1 (0.2) | 0 (0.0) | ||
Check for virginity | 1 (0.1) | 0 (0.0) | 1 (0.2) | 0 (0.0) | ||
Don't know | 20 (2.1) | 4 (1.1) | 15 (3.2) | 1 (1.2) |
Bold p-values indicate p < 0.05.
Sample restricted to MBMT-3 participants who self-identified as White or Black or Latina/Hispanic (n = 47 participants were excluded due to missing race and ethnicity or a self-identification as other than White, Black, or Latina/Hispanic). White or Black identification based on participant response to the multiple-choice question: “What is your race or ethnicity?” Latina/Hispanic identification based on participant response to the question: “Are you Latina or Hispanic?”
p-Value comparing responses among Black versus White participants (reference), using logistic regression.
p-Value comparing responses among Latina/Hispanic versus White participants (reference), using logistic regression.
Participants' open-ended responses to the question “What is the purpose of a Pap smear?” were transcribed directly by interviewers. Open-ended text responses were then coded by two independent study team members into the categories displayed. Responses may be included in more than one category, so the total number of unique responses (n = 935) is larger than the total number of participants.
HPV, human papillomavirus; MBMT-3, My Body My Test-3.